|
Al Altomari
Chief Executive Officer, Barrier Therapeutics, Inc.
Edwin A. Bescherer, Jr
Retired Chief Financial Officer, Dun & Bradstreet Corporation
Rolf Classon, Auxilium, Chairman of the Board
Chairman of the Board of Hillenbrand Industries Inc., Former Chairman of the Executive Committee of Bayer HealthCare AG
Philippe O. Chambon, MD, PhD
Managing Director of New Leaf Venture Partners, LLC
Oliver Fetzer, PhD
Senior Vice President, Corporate Development and Research and Development, Cubist Pharmaceuticals
Armando Anido
Chief Executive Officer and President
Dennis J. Purcell
Senior Managing Partner of Aisling Capital LLC
Renato Fuchs, Ph.D.
Retired Senior Vice President, Manufacturing and Technical Operations, Altus Pharmaceuticals,
Inc.
Dennis H. Langer, M.D., J.D.
Managing Partner, Phoenix IP Ventures, LLC
|